Metabolic & Incretin Research

≥99.2%
CAS:2023788-19-2
Tirzepatide (TR5 / 5mg)
5mg Lyophilized Vial
High-purity dual agonist research standard in sealed 5mg sterile vial.
COA & HPLC Verified2 Files

Laboratory bulk formulation vial with verified sterility and endotoxin assay.
Laboratory Research Disclaimer: This chemical compound is sold strictly for analytical, in vitro, and laboratory research investigations. Not approved for human or veterinary administration.
Certified analytical research vials in 5 verified packaging specifications. Direct B2B batch allocation available.
| Cat. No | Configuration / Name | Packaging Spec | Purity / QC | Stock Status | Actions |
|---|---|---|---|---|---|
| TR5 | Tirzepatide 5mg (TR5) | 5mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) | |
| TR10 | Tirzepatide 10mg (TR10) | 10mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) | |
| TR15 | Tirzepatide 15mg (TR15) | 15mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) | |
| TR20 | Tirzepatide 20mg (TR20) | 20mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) | |
| TR30 | Tirzepatide 30mg (TR30) | 30mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) |

High-purity dual agonist research standard in sealed 5mg sterile vial.

Analytical grade Tirzepatide research vial with validated HPLC chromatogram.

Dual GIP/GLP-1 receptor co-agonist peptide standard for laboratory studies.